4.5 Article

Receptor Recycling by Retromer

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 43, Issue 7, Pages 317-334

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/10985549.2023.2222053

Keywords

retromer; VPS35; endosome; neurodegeneration; cell trafficking

Ask authors/readers for more resources

The retromer complex regulates the fate of receptors in the endolysosomal system and plays a central role in metabolic processes. This review focuses on the assembly of retromer components and how it interacts with endosomal membranes to sort cargo receptors. The article also explores the regulation of retromer in different metabolic states and its involvement in various diseases and microbial infections.
The highly conserved retromer complex controls the fate of hundreds of receptors that pass through the endolysosomal system and is a central regulatory node for diverse metabolic programs. More than 20 years ago, retromer was discovered as an essential regulator of endosome-to-Golgi transport in yeast; since then, significant progress has been made to characterize how metazoan retromer components assemble to enable its engagement with endosomal membranes, where it sorts cargo receptors from endosomes to the trans-Golgi network or plasma membrane through recognition of sorting motifs in their cytoplasmic tails. In this review, we examine retromer regulation by exploring its assembled structure with an emphasis on how a range of adaptor proteins shape the process of receptor trafficking. Specifically, we focus on how retromer is recruited to endosomes, selects cargoes, and generates tubulovesicular carriers that deliver cargoes to target membranes. We also examine how cells adapt to distinct metabolic states by coordinating retromer expression and function. We contrast similarities and differences between retromer and its related complexes: retriever and commander/CCC, as well as their interplay in receptor trafficking. We elucidate how loss of retromer regulation is central to the pathology of various neurogenerative and metabolic diseases, as well as microbial infections, and highlight both opportunities and cautions for therapeutics that target retromer. Finally, with a focus on understanding the mechanisms that govern retromer regulation, we outline new directions for the field moving forward.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available